Literature DB >> 17276648

[Validation of a questionnaire to screen for harmful use of alcohol and cannabis in the general population: CRAFFT-ADOSPA].

Laurent Karila1, Stéphane Legleye, François Beck, Emmanuelle Corruble, Bruno Falissard, Michel Reynaud.   

Abstract

BACKGROUND: Adolescents and young adults seeing a nurse or physician for any reason should be screened for psychoactive substance use. Several English-language questionnaires are available to screen for and assess harmful use of psychoactive substances among adolescents, but to our knowledge, no such instrument exists in French. The aim of the ADOTECNO study was therefore to develop simple and efficient tools for this purpose.
METHODS: Two questionnaires widely used in French epidemiologic studies (CRAFFT-ADOSPA to screen for harmful use and POSIT to assess the seriousness of consumption from physical, psychological and social viewpoints) were completed by 1728 secondary and post-secondary school students. Statistical analyses assessed correlations between the questionnaires and calibrated optimal cutoff points for the different tools included in ADOTECNO.
RESULTS: Correlations between psychoactive substance consumption, responses to the CRAFFT-ADOSPA questionnaire, and POSIT factor A scores showed that CRAFFT-ADOSPA provided early detection of regular alcohol intoxication and of regular and daily cannabis use. At a score of 2, CRAFFT-ADOSPA detects harmful substance use, and at a score higher than or equal to 3 it demonstrates serious substance use.
CONCLUSION: These findings enabled us to recommend useful cutoff values for the CRAFFT-ADOSPA tools for screening subjects at moderate or high risk of substance abuse. This simple broad screening should be complemented for the subjects found to be at risk by a computer-assisted POSIT to guide practitioners in selecting an approach (educational, school, family, psychological, psychiatric, etc.) to care and management according to the specific types of impairment resulting from substance use.

Entities:  

Mesh:

Year:  2007        PMID: 17276648     DOI: 10.1016/j.lpm.2007.01.005

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  8 in total

1.  Do reward-processing deficits in schizophrenia-spectrum disorders promote cannabis use? An investigation of physiological response to natural rewards and drug cues.

Authors:  Clifford M Cassidy; Mathieu B Brodeur; Martin Lepage; Ashok Malla
Journal:  J Psychiatry Neurosci       Date:  2014-09       Impact factor: 6.186

2.  Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL study.

Authors:  Caroline Victorri-Vigneau; Céline Verstuyft; Régis Bouquié; Edouard-Jules Laforgue; Jean-Benoit Hardouin; Juliette Leboucher; Bertrand Le Geay; Corine Dano; Gaëlle Challet-Bouju; Marie Grall-Bronnec
Journal:  Br J Clin Pharmacol       Date:  2019-05-11       Impact factor: 4.335

3.  Prevalence of binge drinking and associated behaviours among 3286 college students in France.

Authors:  Marie-Pierre Tavolacci; Eloïse Boerg; Laure Richard; Gilles Meyrignac; Pierre Dechelotte; Joël Ladner
Journal:  BMC Public Health       Date:  2016-02-23       Impact factor: 3.295

4.  Prevalence of Coaddictions and Rate of Successful Treatment Among a French Sample of Opioid-Dependent Patients With Long-Term Opioid Substitution Therapy: The OPAL Study.

Authors:  Marie Grall-Bronnec; Edouard-Jules Laforgue; Gaëlle Challet-Bouju; Jennyfer Cholet; Jean-Benoit Hardouin; Juliette Leboucher; Morgane Guillou-Landréat; Caroline Victorri-Vigneau
Journal:  Front Psychiatry       Date:  2019-10-17       Impact factor: 4.157

5.  The efficacy of a targeted PREVENTION programme for addictive behaviour (PREVENTURE) among vulnerable ADOlescents in France - study procotol.

Authors:  Morgane Guillou-Landreat; Elkhan Tahmazov; Schreck Benoit; Marie Grall-Bronnec; Patricia Conrod; Audrey Livet; Emmanuel Nowak; Jean -Yves Le Reste
Journal:  BMC Public Health       Date:  2021-04-23       Impact factor: 3.295

6.  What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report.

Authors:  Morgane Guillou-Landreat; Antoine Dany; Gaëlle Challet-Bouju; Edouard Laforgue; Juliette Leboucher; Jean Benoit Hardouin; Caroline Victorri-Vigneau; Marie Grall-Bronnec
Journal:  Int J Environ Res Public Health       Date:  2021-02-03       Impact factor: 3.390

7.  How do people who use drugs receiving Opioid Medication Therapy perceive their treatment ? A multicentre study.

Authors:  Morgane Guillou Landreat; Antoine Dany; Gaelle Challet Bouju; Edouard-Jules Laforgue; J Cholet; Juliette Leboucher; Jean Benoit Hardouin; Caroline Victorri Vigneau; Marie Grall Bronnec
Journal:  Harm Reduct J       Date:  2022-03-28

8.  Prevalence and association of perceived stress, substance use and behavioral addictions: a cross-sectional study among university students in France, 2009-2011.

Authors:  Marie Pierre Tavolacci; Joel Ladner; Sebastien Grigioni; Laure Richard; Herve Villet; Pierre Dechelotte
Journal:  BMC Public Health       Date:  2013-08-06       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.